Net Income for Edwards Lifesciences (EW)
According to Edwards Lifesciences's latest reported financial statements, the company's current net income (TTM) is $1.09B USD. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingNet IncomeSwitch metric
TTM (last 4 quarters)
$1.09B
YoY change
-74.3%
5Y CAGR
+5.4%
Peak year (2024)
$4.17B
Cumulative net income
$16.52B
Net Income history chart for Edwards Lifesciences (EW) from 1999 to 2025
Net Income history table for Edwards Lifesciences (EW) from 1999 to 2025
| Fiscal year | Period ended | Reported | Net Income | YoY |
|---|---|---|---|---|
| 2025 | $1.07B | -74.3% | ||
| 2024 | $4.17B | +197.7% | ||
| 2023 | $1.40B | -7.9% | ||
| 2022 | $1.52B | +1.3% | ||
| 2021 | $1.50B | +82.5% | ||
| 2020 | $823.40M | -21.3% | ||
| 2019 | $1.05B | +45.0% | ||
| 2018 | $722.20M | +16.1% | ||
| 2017 | $622.10M | +9.2% | ||
| 2016 | $569.50M | +15.1% | ||
| 2015 | $494.90M | -39.0% | ||
| 2014 | $811.10M | +107.1% | ||
| 2013 | $391.70M | +33.6% | ||
| 2012 | $293.20M | +23.9% | ||
| 2011 | $236.70M | +8.6% | ||
| 2010 | $218.00M | -4.8% | ||
| 2009 | $229.10M | +77.7% | ||
| 2008 | $128.90M | +14.1% | ||
| 2007 | $113.00M | -13.4% | ||
| 2006 | $130.50M | +64.6% | ||
| 2005 | $79.30M | +4564.7% | ||
| 2004 | $1.70M | -97.8% | ||
| 2003 | $79.00M | +41.8% | ||
| 2002 | $55.70M | -564.2% | ||
| 2001 | -$12.00M | -95.6% | ||
| 2000 | -$272.00M | -431.7% | ||
| 1999 | $82.00M | — |
Net Income values are taken from Edwards Lifesciences's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Edwards Lifesciences (EW) net income is $1.07B – plunged 74.3% year-over-year.
Across 2020–2025 (5 years), Edwards Lifesciences net income produced a CAGR of +5.4% – with the latest reading among the more recent periods of the dataset.
Between 2024 and 2025, Edwards Lifesciences net income plunged 74.3%, falling from $4.17B to $1.07B.
2024 marks the peak net income at $4.17B, with the historical low of -$272.00M recorded in 2000.
Within Healthcare, Edwards Lifesciences (EW) ranks 9th among 8 peers we track. The peer median for net income is $15.15B.
Edwards Lifesciences Net Income by Year
Edwards Lifesciences Net Income 2025: $1.07B
Edwards Lifesciences net income in 2025 was $1.07B, plunged 74.3% below 2024.
Edwards Lifesciences Net Income 2024: $4.17B
Edwards Lifesciences net income in 2024 was $4.17B, surged 197.7% from 2023. This figure represents the highest annual value in the available history.
Edwards Lifesciences Net Income 2023: $1.40B
Edwards Lifesciences net income in 2023 was $1.40B, declined 7.9% below 2022.
Edwards Lifesciences Net Income 2022: $1.52B
Edwards Lifesciences net income in 2022 was $1.52B, edged up 1.3% from 2021.
Edwards Lifesciences Net Income 2021: $1.50B
Edwards Lifesciences net income in 2021 was $1.50B.
See more financial history for Edwards Lifesciences (EW).
Sector peers — Net Income
Companies in the same sector as Edwards Lifesciences, ranked by their latest net income.
| Company | Net Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $102.43B | Healthcare |
| Johnson & Johnson (JNJ) | $26.80B | Healthcare |
| Eli Lilly and Company (LLY) | $20.64B | Healthcare |
| Merck & Co., Inc. (MRK) | $18.25B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $12.06B | Healthcare |
| AstraZeneca PLC (AZN) | $10.26B | Healthcare |
| Amgen Inc. (AMGN) | $7.71B | Healthcare |
| AbbVie Inc. (ABBV) | $4.23B | Healthcare |
Frequently asked questions
What is Edwards Lifesciences's net income?
- Latest reported net income for Edwards Lifesciences (EW) is $1.09B (period ending March 31, 2026).
How has Edwards Lifesciences net income changed year-over-year?
- Edwards Lifesciences (EW) net income changed -74.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Edwards Lifesciences net income?
- Edwards Lifesciences (EW) net income compound annual growth rate is +5.4% over the most recent 5 years available.
When did Edwards Lifesciences net income hit its highest annual value?
- Edwards Lifesciences net income reached its highest annual value of $4.17B in 2024.
What was Edwards Lifesciences net income in 2024?
- Edwards Lifesciences (EW) net income in 2024 was $4.17B.
What was Edwards Lifesciences net income in 2025?
- Edwards Lifesciences (EW) net income in 2025 was $1.07B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
EW Overview
Company profile, financial tools, and key metrics
EW Revenue Counter
Earns $199.88 every second. See per minute, hour, and day.
EW Earnings Counter
Earns $34.65 per second net profit. See per minute, hour, and day.
EW Economic Scale
Exceeds Fiji's GDP. Compare with world economies.
EW What If Invested
What if you had invested $1,000? See historical returns from any date.
EW How It Makes Money
Discover visual breakdown of $6.30B in revenue — where it comes from and where it goes.
EW Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
EW Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
EW Daily Price Character
Balanced · 50.0% historical win rate (green days). Streaks & record days.
EW Buybacks
0.93% TTM buyback yield. Shareholder yield & SBC comparison.
EW Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.